Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
31 /100
COMPONENT-LIMITED
Score updated Oct 13, 2026

SGMT — Sagimet Biosciences Inc. Dilution Risk Tracker

Track SGMT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SGMT — Get alerts when the score changes →

As of October 13, 2026, Sagimet Biosciences Inc. (SGMT) has a DilutionWatch DilutionScore of 31/100, rated MEDIUM dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Sagimet Biosciences Inc. has a market capitalization of $269.94M, 30.67M shares outstanding, 87 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $75.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
0
📊Float Risk—
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise model 18%
• Active ATM program with $75M remaining capacity
🔔 Track SGMT — Get forecast alerts →

Market Data

Market Cap$269.94M
Shares Outstanding30.67M
FloatN/A
Cash$240.13M
Debt$39.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore31/100DilutionWatch score record
Shares Outstanding30.67MVerified float table or market cache
Public FloatNot availableVerified float table or market cache
Market Cap$269.94MMarket data cache
Cash Runway79.1 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$75.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 3, 424B5 1, 8-K 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 2.1% shares (2026Q1 vs prior)
87 institutional holders · 16.53M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 2.20M shares
#2 Woodline Partners LP 2.00M shares
#3 MARSHALL WACE, LLP 966.3K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest11.19M
Days to Cover6.7
% of FloatN/A
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-03-12
424B5 ATM 2026-04-28
8-K 8K EVENT 2026-04-28
4 INSIDER TRANSACTION 2026-02-20
4 INSIDER TRANSACTION 2026-02-20
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual SGMT Dilution Snapshot

Sagimet Biosciences Inc. (SGMT) has a DilutionScore of 31/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

SGMT's DilutionScore is currently 31/100 (Medium risk), with 3 score changes tracked over 89 days. The score improved from 24/100 (Low risk).

Period Score Risk Level Duration
Sep 30 – Oct 13, 202631/100MEDIUM14 days
Aug 22 – Sep 29, 202624/100LOW39 days
Aug 14 – Aug 21, 202627/100MEDIUM7 days
Jul 16 – Aug 13, 202634/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

SGMT shares outstanding have increased 97.4% from 31.00M (Mar 2026) to 61.18M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 15, 202661.18M59.14M▲ 89.51%
May 03, 202661.18M31.21M▲ 4.11%
Mar 14, 202631.00M29.98M▲ 3.31%
Mar 13, 202631.00M29.02M▲ 0.20%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track SGMT Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment SGMT files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking SGMT — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for SGMT
SGMT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.